Anand Srinivasan to Abatacept
This is a "connection" page, showing publications Anand Srinivasan has written about Abatacept.
Connection Strength
0.050
-
Abatacept-based Graft-Versus-Host Disease Prophylaxis in Haplo-identical Hematopoietic Cell Transplant in a High-risk Cohort. J Pediatr Hematol Oncol. 2022 10 01; 44(7):383-387.
Score: 0.050